Chemomab Therapeutics Names Jack Lawler Vice President of Global Clinical Development Operations
- Tuesday, January 4, 2022, 7:14
- PR Newswire
- Add a comment
TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ — Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today named Jack…
About the Author
admin has written 21793 stories on this site.